Vitrology

Glasgow, United Kingdom Founded: 2007 • Age: 19 yrs Acquired By SGS
Biosafety testing for biologics is conducted to ensure compliance.

About Vitrology

Vitrology is a company based in Glasgow (United Kingdom) founded in 2007 was acquired by SGS in May 2012. Vitrology operates in a competitive market with competitors including G-Con Manufacturing, Comecer, NuAire, Noroit and Landauer, among others.

  • Headquarter Glasgow, United Kingdom
  • Sectors
    Healthcare
  • Email
    β€’β€’β€’β€’β€’β€’β€’β€’
  • Phone
    β€’β€’β€’β€’ β€’β€’β€’β€’
  • Website vitrologybiotech.com
  • Social LinkedIn X Facebook
  • Acquired by SGS (May 2012)
Key Metrics

Funding Insights of Vitrology

  • Total Rounds 1
  • Investors Count 1

All 1 funding rounds of Vitrology with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.

DateAmountTransaction NameValuationLead InvestorsInvestors
Jun 2007–Seed––
Valuation history

2 investors in total: 2 institutional.

Investors in Vitrology

Vitrology has secured backing from 2 investors, including venture fund and institutional investors. Prominent investors backing the company include SGS and Archangels.

All
Venture Fund
Institutional
InvestorDescriptionFounded YearDomainLocation
Investment and expertise are provided to early-stage Scottish companies.
–archangelsonline.comEdinburgh, Scotland
Product inspection, testing, and digital transformation services are provided.
1878sgs.comGeneva, Switzerland
Premium access

Investor details for Vitrology

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

Timeline of Vitrology

3 dated milestones of Vitrology across 5 years, from founding to its latest funding, stage changes and deals.

  1. Founded Vitrology is founded.
  2. Funding First funding round.
  3. Exit Acquired by SGS.

Competitors of Vitrology

Vitrology operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as G-Con Manufacturing, Comecer, NuAire, Noroit and Landauer, among others.

Company NameDomainFoundedHQ LocationTotal fundingEmployeesDescription
gconbio.com2009College Station, United States$13M43
Builds and installs prefabricated, autonomous cleanrooms
comecer.com1974Castel Bolognese, Italy$10.57M4
Protective equipment and containment systems for nuclear medicine, nuclear power plants and aseptic manufacturing
nuaire.com1971Plymouth, United Kingdom–265
Laboratory safety equipment is manufactured for research and industrial use.
noroitlabo.com2006Bouaye, France$496,282–
Developer of protective equipment against biological risks for research, pharma and hospital sectors
landauer.com1954Glenwood, United States––
Radiation monitoring and protection
virustatic.com2009Stockport, United Kingdom–1
Anti-viral technology for face masks is developed by Virustatic.
isolationsciences.com2006Williamsville, United States$150,000–
Fume hood retrofit kits with movable access ports are manufactured.
biosci-intl.com1996Rockville, United States–10
Manufactures air sampling equipment to detect contamination in food, pharmaceutical, and hospital environments.
genetoo.com2017Rehoboth Beach, United States––
Aseptic surfaces for medical implants are created via laser technology.
Premium access

Detailed competitors of Vitrology

The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.

  • Full competitor set
  • Operating metrics
  • Benchmarks
  • Competitive positioning

Verified entity values are shown only after access is granted.

Similar companies to Vitrology

10 companies that operate in the same segment as Vitrology (Life Sciences Platforms & Tools), ranked by their profile score on The Company Check.

CompanyDescriptionFoundedLocationTotal fundingRevenueEmployees
Medidata is recognized as a leading provider of SaaS solutions for clinical research.
1999New York, New York, United StatesUSD 41.5 M––
AI-based solutions for health management are provided.
2015Dallas, Texas, United StatesUSD 2.8 B––
Nanopore-based electronic systems for single-molecule analysis are developed.
2005Oxford, Oxfordshire, United KingdomUSD 1.3 BUSD 301.49 M1,480
Real-world health data is provided for research and decisions.
2012Menlo Park, California, United StatesUSD 259.16 M––
Genetically modified cell lines are developed using AAV gene-editing platform.
2007Cambridge, Cambridgeshire, United KingdomUSD 46.29 M––
Biological reagents and antibodies are developed for life science research.
1998Cambridge, Cambridgeshire, United KingdomUSD 78.8 M––
Electron microscopy services and microanalysis instruments are provided.
1956Waltham, Massachusetts, United States–USD 44.56 B125,000
Novel therapeutics are discovered using an AI-enabled drug platform.
2013New York, New York, United StatesUSD 456.66 MUSD 74.68 M–
A platform for sharing and accessing academic research papers is provided.
2008San Francisco, California, United StatesUSD 58.4 M––
Developer of molecular diagnostic testing solutions
1996Sunnyvale, California, United StatesUSD 19.1 MUSD 54.88 M208
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Frequently Asked Questions about Vitrology

Vitrology was founded in 2007.

Vitrology is headquartered in Glasgow, United Kingdom. It is registered at Glasgow, Scotland, United Kingdom.

Vitrology engages in biosafety testing services for biologics to ensure the safety of biopharmaceuticals and vaccines by confirming the absence of contaminants and complying with regulations. It offers the following services cell bank and virus seeds characterization to ICH EP FDA JP guidelines, raw material and bulk harvest testing (sterility, mycoplasma, viruses, electron microscopy), final product testing for Residual DNA, regulatory and safety consultancy services, and custom development of assays. The company got acquired by SGS UK in May, 2012.

Vitrology's top competitors include G-Con Manufacturing, Comecer and NuAire.

Vitrology has 2 investors. Key investors include SGS, and Archangels.

Yes. Vitrology was acquired by SGS in May 2012.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available